About us

about-us_img01

Orifarm was founded in Denmark in 1994 by Birgitte and Hans Bøgh-Sørensen. Starting out with an entrepreneurial mission, later re-named the ‘explorer spirit’. This concept describes a company culture in which we are always looking for new ways to develop and improve, with respect for both quality and the individuals in our company.

Global pharmaceutical company

Using our position as a fully integrated global pharmaceutical company with a unique combination of fully owned product lines and as Europe’s number 1 Pharmaceutical trade business, we are able to shift the procurement dynamic from the standard transactional approach to a data and market intelligence driven supply chain. Our unrivalled product access enables us to provide a more reliable and economical service to our clients, helping them to focus on the important task of researching and developing new treatments.

Orifarm CTS/Pilatus Aquisition

1994

Orifarm was founded by Birgitte and Hans Bøgh-Sørensen.

1995 - 2005

Organic growth within Orifarm Health Access to the rest of the Nordic countries and Orifarm Healthcare starts.

2006

Acquisition of Pharma Western, Germany (Orifarm Health Access).

2008 - 2010

Profit focus and split of Orifarm Trade and Orifarm Healthcare and establishment of professional and international Board of Directors.

2013

Production and inbound logistics setup in the Czech Republic.

2015

Orifarm acquires Growth House Holding including the companies Alternova, Viminco, and Pilum Pharma.

2015 - 2018

Entry in the Netherlands, the United Kingdom, and Austria.

2019

Orifarm acquires the company Pilatus Comparator Solutions with activities in the U.K., Germany, and the U.S.

2020

Acquisition from Takeda. The acquisition includes more than 100 pharmaceuticals and dietary supplements as well as approximately 600 employees.

2020

To ensure Orifarm remains family-owned in the future, the next step of the succession is completed, as Birgitte and Hans Bøgh-Sørensen transfer further company shares to their three children. Hans Bøgh-Sørensen remains Chairman of the Board of Directors and continues to have the majority voting right.

2022

Orifarm focuses on building the foundation for further growth, as the company continues to grow into a larger, international player.

Our Team

Nick Evans

Nick Evans

Head of Global CTS Client Services

Tony Street (1)

Tony Street

Vice President, CTS & General Manager, UK Sales

Catherine Hayes

Catherine Hayes

Head of Business Intelligence, CTS

Michelle Devine

Michelle Devine

Business Development Director

Ruth Smiley

Ruth Smiley

Global Marketing Manager, CTS

Vinit Patel

Vinit Patel

Account Manager, CTS